Overexpression of the c-MET/HGF receptor gene in human thyroid carcinomas.

No abstract is available for this paper.

• Publication year

  1992

• Venue

  Oncogene

• Publication date

  1992-12-01

• Fields of study

  Biology, Medicine

• Identifiers
  PMID 1334253
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• TRK-T1 is a novel oncogene formed by the fusion of TPR and TRK genes in human papillary thyroid carcinomas.

  1992cited by this paper
• gsp mutations in human thyroid tumours.

  1991cited by this paper
• The receptor encoded by the human C‐MET oncogene is expressed in hepatocytes, epithelial cells and solid tumors

  1991cited by this paper
• Evaluation of immunoreactivity for erbB-2 protein as a marker of poor short term prognosis in gastric cancer.

  1991cited by this paper
• c-met is amplified but not mutated in a cell line with an activated met tyrosine kinase.

  1991cited by this paper
• Expression of the Met/HGF receptor in normal and neoplastic human tissues.

  1991cited by this paper
• Hepatocyte growth factor (HGF) stimulates the tyrosine kinase activity of the receptor encoded by the proto-oncogene c-MET.

  1991cited by this paper
• BEK and FLG, two receptors to members of the FGF family, are amplified in subsets of human breast cancers.

  1991cited by this paper
• Evidence for the identity of human scatter factor and human hepatocyte growth factor.

  1991cited by this paper
• C-terminal truncated forms of Met, the hepatocyte growth factor receptor

  1991cited by this paper
• Identification of the hepatocyte growth factor receptor as the c-met proto-oncogene product.

  1991cited by this paper
• Scatter factor and hepatocyte growth factor are indistinguishable ligands for the MET receptor.

  1991cited by this paper
• Partial transformation of human thyroid epithelial cells by mutant Ha-ras oncogene.

  1990cited by this paper
• Presence of mutations in all three ras genes in human thyroid tumors.

  1990cited by this paper
• Tissue distribution of hepatopoietin-A: a heparin-binding polypeptide growth factor for hepatocytes.

  1990cited by this paper
• PTC is a novel rearranged form of the ret proto-oncogene and is frequently detected in vivo in human thyroid papillary carcinomas.

  1990cited by this paper
• Inverse relationship of epidermal growth factor receptor and HER2/neu gene expression in human renal cell carcinoma.

  1990cited by this paper
• Overexpression of HER-2/neu is associated with poor survival in advanced epithelial ovarian cancer.

  1990cited by this paper
• Tyrosine kinase receptor indistinguishable from the c-met protein

  1989cited by this paper
• Biosynthesis of the protein encoded by the c-met proto-oncogene.

  1989cited by this paper
• Expression pattern of the neu (NGL) gene-encoded growth factor receptor protein (p185neu) in normal and transformed epithelial tissues of the digestive tract.

  1989cited by this paper
• Studies of the HER-2/neu proto-oncogene in human breast and ovarian cancer.

  1989cited by this paper
• NH2-terminal amino acid sequence of rabbit hepatopoietin A, a heparin-binding polypeptide growth factor for hepatocytes.

  1989cited by this paper
• Amplification, overexpression, and rearrangement of the erbB-2 protooncogene in primary human stomach carcinomas.

  1989cited by this paper
• High frequency of ras oncogene activation in all stages of human thyroid tumorigenesis.

  1989cited by this paper
• Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor.

  1989cited by this paper
• High frequency of activation of tyrosine kinase oncogenes in human papillary thyroid carcinoma.

  1989cited by this paper
• Amplification of the EGF receptor and c‐myc genes in human esophageal cancers

  1988cited by this paper
• Prognostic Implications of the Tall Cell Variant of Papillary Thyroid Carcinoma

  1988cited by this paper
• Detection of activated ras oncogenes in human thyroid carcinomas.

  1988cited by this paper
• Columnar-cell carcinoma. Another variant of poorly differentiated carcinoma of the thyroid.

  1988cited by this paper
• p145, a protein with associated tyrosine kinase activity in a human gastric carcinoma cell line

  1988cited by this paper
• Characterization of the TPR-MET oncogene p65 and the MET protooncogene p140 protein-tyrosine kinases.

  1988cited by this paper
• Activated ras oncogenes in human thyroid cancers.

  1988cited by this paper
• Scatter factor is a fibroblast-derived modulator of epithelial cell mobility

  1987cited by this paper
• Unique fusion of bcr and c-abl genes in Philadelphia chromosome positive acute lymphoblastic leukemia.

  1987cited by this paper
• Increased expression of the epidermal growth factor receptor gene in malignant gliomas is invariably associated with gene amplification.

  1987cited by this paper
• A new oncogene in human thyroid papillary carcinomas and their lymph-nodal metastases

  1987cited by this paper
• Mapping of four distinct BCR-related loci to chromosome region 22q11: order of BCR loci relative to chronic myelogenous leukemia and acute lymphoblastic leukemia breakpoints.

  1987cited by this paper
• Human breast cancer: correlation of relapse and survival with amplification of the HER-2/neu oncogene.

  1987cited by this paper
• The chronic myelogenous leukemia-specific P210 protein is the product of the bcr/abl hybrid gene.

  1986cited by this paper
• High incidence of amplification of the epidermal growth factor receptor gene in human squamous carcinoma cell lines.

  1986cited by this paper
• Mechanism of met oncogene activation.

  1986cited by this paper
• Amplification, enhanced expression and possible rearrangement of EGF receptor gene in primary human brain tumours of glial origin

  1985cited by this paper
• The human met oncogene is related to the tyrosine kinase oncogenes

  1985cited by this paper
• Molecular cloning of a new transforming gene from a chemically transformed human cell line

  1984cited by this paper
• Human squamous cell lung cancers express increased epidermal growth factor receptors.

  1984cited by this paper
• Poorly differentiated carcinoma of the thyroid. A clinicopathologic entity for a high‐risk group of papillary and follicular carcinomas

  1983cited by this paper
• Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications.

  1979cited by this paper
• Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4

  1970cited by this paper

• HGF/C-Met Expression in Epithelial Ovarian Carcinogenesis and Its Potential as Molecular Targeted Therapy

  2023cites this paper
• Identification of DPP4/CTNNB1/MET as a Theranostic Signature of Thyroid Cancer and Evaluation of the Therapeutic Potential of Sitagliptin

  2022cites this paper
• Thyroid cancer under the scope of emerging technologies.

  2021cites this paper
• Roles of MET in Human Cancer.

  2021cites this paper
• Thyroid Cancer and Circadian Clock Disruption

  2020cites this paper
• Dual inhibition of RNAi therapeutic miR-26a-5p targeting cMet and immunotherapy against EGFR in endometrial cancer treatment

  2020cites this paper
• Canine Thyroid Cancer: Molecular Characterization and Cell Line Growth in Nude Mice

  2020cites this paper
• Bayesian Framework for Detecting Gene Expression Outliers in Individual Samples.

  2020cites this paper
• MET targeting: time for a rematch

  2020cites this paper
• MET exon 14 skipping mutations and gene amplification in a Taiwanese lung cancer population

  2019cites this paper
• Targeting the C-MET/HGF Signaling Pathway in Pancreatic Ductal Adenocarcinoma.

  2019cites this paper
• Downregulation of long non-coding RNA TUG1 suppresses tumor growth by promoting ubiquitination of MET in diffuse large B-cell lymphoma

  2019cites this paper
• Phage display screening of therapeutic peptide for cancer targeting and therapy

  2019cites this paper
• 12 Differentiation Therapy in Thyroid Carcinoma

  2018cites this paper
• Эффективность дистанционной лучевой терапии и таргетной терапии вандетанибом нерезектабельного и прогрессирующего медуллярного рака щитовидной железы

  2018cites this paper
• The Emerging Role of Insulin Receptor Isoforms in Thyroid Cancer: Clinical Implications and New Perspectives

  2018cites this paper
• The role of GSK3 and its reversal with GSK3 antagonism in everolimus resistance.

  2018cites this paper
• Receptor Tyrosine Kinase-Targeted Cancer Therapy

  2018cites this paper
• Activated HGF-c-Met Axis in Head and Neck Cancer

  2017cites this paper
• MET exon 14 juxtamembrane splicing mutations: clinical and therapeutical perspectives for cancer therapy.

  2017cites this paper
• Insulin Receptor Isoforms in Physiology and Disease: An Updated View

  2017cites this paper
• Low doses of TiO2-polyethylene glycol nanoparticles stimulate proliferation of hepatocyte cells

  2016cites this paper
• Comparative survival analysis of the treatment options for TKI resistant advanced non-small cell lung cancer ( NSCLC ) patients : a meta-analysis

  2016cites this paper
• MET receptor is a potential therapeutic target in high grade cervical cancer

  2015cites this paper
• Identification of potential therapeutic targets for papillary thyroid carcinoma by bioinformatics analysis

  2015cites this paper
• Break-apart interphase fluorescence in situ hybridization assay in papillary thyroid carcinoma: on the road to optimizing the cut-off level for RET/PTC rearrangements.

  2015cites this paper
• Tyrosylprotein sulfotransferase 1 expression is negatively correlated with c‑Met and lymph node metastasis in human lung cancer.

  2015cites this paper
• c-MET and KRAS: Signalling and Clinical Implications in Colorectal Cancer

  2014cites this paper
• Molecular Pathology and Diagnostics of Thyroid and Parathyroid Malignancies

  2014cites this paper
• The Pathogenetic Role of the HGF/c-Met System in Papillary Carcinoma of the Thyroid

  2014cites this paper
• miR-199a-3p displays tumor suppressor functions in papillary thyroid carcinoma

  2014cites this paper
• Reduced membranous MET expression is linked to bladder cancer progression.

  2014cites this paper
• C-Met expression pattern in uterine leiomyoma.

  2014cites this paper
• Monoclonal Antibodies against the MET/HGF Receptor and Its Ligand: Multitask Tools with Applications from Basic Research to Therapy

  2014cites this paper
• Oxidative Stress and Angiogenesis in Tumor Progression

  2013cites this paper
• Biological significance and targeting of c-Met tyrosine kinase receptor in cancer.

  2013cites this paper
• Pax-8 in Human Thyroid Neoplasms Expression of Thyroid-specific Transcription Factors Ttf-1 and Updated Version Citing Articles E-mail Alerts Expression of Thyroid-specific Transcription Factors Ttf-1 and Pax-8 in Human Thyroid Neoplasms1

  2013cites this paper
• Autophagy and thyroid carcinogenesis: genetic and epigenetic links.

  2013cites this paper
• Overexpression of c-Met in cervical intraepithelial neoplasia.

  2012cites this paper
• The pituitary tumor transforming gene in thyroid cancer

  2012cites this paper
• Differentiation Therapy in Thyroid Carcinoma

  2012cites this paper
• Therapeutic potential of c-MET inhibitors: background and clinical data

  2012cites this paper
• Role of genes differentially expressed in thyroid carcinogenesis

  2012cites this paper
• An overview of the c-MET signaling pathway

  2011cites this paper
• Investigating the Biological and Biochemical Consequences of Met Function and Dysfunction in Canine Osteosarcoma

  2011cites this paper
• Discovery of a novel B-Raf fusion protein related to c-Met drug resistance.

  2011cites this paper
• Development of c-MET pathway inhibitors

  2011cites this paper
• Selection criteria for c-Met-targeted therapies: emerging evidence for biomarkers.

  2010cites this paper
• The Ezrin Signalling Network as a Potential Novel Marker in Breast Cancer Metastasis

  2010cites this paper
• Molecular profiling of cutaneous squamous cell carcinoma

  2010cites this paper
• A Practical Manual of Thyroid and Parathyroid Disease

  2010cites this paper
• Thyroid Cancer: Identification of Gene Expression Markers for Diagnosis

  2010cites this paper
• Carcinogenesis and therapeutic strategies in thyroid cancer.

  2010cites this paper
• Signal transduction in the human thyrocyte and its perversion in thyroid tumors.

  2010cites this paper
• Mutational and Immunohistochemical Study of the PI3K/Akt Pathway in Papillary Thyroid Carcinoma in Greece

  2010cites this paper
• Molecular pathogenesis of follicular cell derived thyroid cancers.

  2010cites this paper
• Oncogenesis and Molecular Targeted Therapy in Thyroid Cancer

  2010cites this paper
• Molecular prognostic markers in papillary and follicular thyroid cancer: Current status and future directions.

  2010cites this paper
• Recent Developments in the Molecular Biology of the Thyroid

  2010cites this paper
• Molecular pathogenesis of thyroid cancer: the significance of oncogenes, tumor suppressor genes, and genomic instability

  2009cites this paper
• Trefoil factor 3 (TFF3): a promising indicator for diagnosing thyroid follicular carcinoma.

  2009cites this paper
• Regulation of the HGF-receptor c-met in the thyroid gland

  2009cites this paper
• Preferential binding of anti-cancer drug adriamycin to the Sp1 binding site in c-met promoter region: A spectroscopic and molecular modeling study

  2009cites this paper
• Chapter 7 – Thyroid and Parathyroid Glands

  2009cites this paper
• RET/PTC1-driven neoplastic transformation and proinvasive phenotype of human thyrocytes involve Met induction and beta-catenin nuclear translocation.

  2009cites this paper
• Co-Expression of Plexin-B1 and Met in Human Breast and Ovary Tumours Enhances the Risk of Progression

  2009cites this paper
• Beyond RET: potential therapeutic approaches for advanced and metastatic medullary thyroid carcinoma

  2009cites this paper
• New therapeutic advances in the management of progressive thyroid cancer.

  2009cites this paper
• International Doctorate Program in Molecular Oncology and Endocrinology Doctorate School in Molecular Medicine

  2009cites this paper
• MET and autism susceptibility: family and case–control studies

  2009cites this paper
• COX‐2 is induced by HGF stimulation in Met‐positive thyroid papillary carcinoma cells and is involved in tumour invasiveness

  2009cites this paper
• Loss of the CBX7 gene expression correlates with a highly malignant phenotype in thyroid cancer.

  2008cites this paper
• Ruolo delle alterazioni di Smad4 nelle patologie neoplastiche tiroidee.

  2008cites this paper
• Malignant Phenotype in Thyroid Cancer Gene Expression Correlates with a Highly CBX 7 Loss of the Updated

  2008cites this paper
• Genomic signatures of cancer progression: from in vitro experimental models to prediction of human breast cancer outcome.

  2008cites this paper
• Drug development of MET inhibitors: targeting oncogene addiction and expedience

  2008cites this paper
• Molecular basis of thyroid cancer: role of inflammatory cells and molecules

  2008cites this paper
• Ovarian-type stroma in hepatobiliary cystadenomas and pancreatic mucinous cystic neoplasms: an immunohistochemical study.

  2008cites this paper
• Receptor tyrosine kinase inhibitors in thyroid cancer.

  2008cites this paper
• Receptors for the liver synthesized growth factors IGF‐1 and HGF/SF in uveal melanoma: intercorrelation and prognostic implications

  2008cites this paper
• Genetic background of carcinogenesis in the thyroid gland.

  2007cites this paper
• Polypeptide growth factors in gastroenteropancreatic neuroendocrine tumours Czynniki wzrostu w guzach neuroendokrynnych przewodu pokarmowego

  2007cites this paper
• Mutation and expression analyses of the MET and CDKN2A genes in rhabdomyosarcoma with emphasis on MET overexpression

  2007cites this paper
• The role of the HGF regulatory factors in breast cancer

  2007cites this paper
• Activating Transcription Factor-1-mediated Hepatocyte Growth Factor-induced Down-regulation of Thrombospondin-1 Expression Leads to Thyroid Cancer Cell Invasion*

  2007cites this paper
• Identification of a Met-Binding Peptide from a Phage Display Library

  2007cites this paper
• Neurotrophic factor regulation of gene expression in primary sensory neurons of the mouse

  2007cites this paper
• Increased expression of mRNA specific for c-Met oncogene in human papillary thyroid carcinoma

  2007cites this paper
• A novel small molecule Met inhibitor, PF2362376, exhibits biological activity against osteosarcoma.

  2007cites this paper
• Polypeptide growth factors in gastroenteropancreatic neuroendocrine tumours.

  2007cites this paper
• Hypoxia-driven selection of the metastatic phenotype

  2007cites this paper
• Insights into the structure/function of hepatocyte growth factor/scatter factor from studies with individual domains.

  2007cites this paper
• Diacylglycerol kinase is required for HGF-induced invasiveness and anchorage-independent growth of MDA-MB-231 breast cancer cells.

  2007cites this paper
• Identification of aMet-Binding Peptide from a Phage Display Library

  2007cites this paper
• Molecular Pathogenesis of Thyroid Cancer

  2006cites this paper
• Detection ofMET oncogene/hepatocyte growth factor receptor in lymph node metastases from head and neck squamous cell carcinomas

  2006cites this paper
• The significance of prohibitin and c-Met/hepatocyte growth factor receptor in the progression of cervical adenocarcinoma.

  2006cites this paper
• No evidence of ARAF, CRAF and MET mutations in BRAFT1799A negative human papillary thyroid carcinoma.

  2006influential citation
• Molecular characterization of well-differentiated human thyroid carcinomas by cDNA arrays.

  2006cites this paper
• Cell Motility in Cancer Invasion and Metastasis

  2006cites this paper